Ventral Hernia Mesh Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mesh Type (Resorbable Mesh, Partially Absorbable Mesh, Non-Resorbable Mesh), By Indication (Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others), By End Use (Inpatient Facilities, Outpatient Facilities), By Region and Competition, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 875.23 Million
CAGR (2026-2031)	8.52%
Fastest Growing Segment	Robotic Surgery
Largest Market	North America
Market Size (2031)	USD 1429.49 Million

Market Overview

The Global Ventral Hernia Mesh Devices Market is projected to grow from USD 875.23 Million in 2025 to USD 1429.49 Million by 2031 at a 8.52% CAGR. Ventral hernia mesh devices are implantable surgical materials engineered to reinforce compromised abdominal wall tissues, thereby preventing recurrence following ventral hernia repair. The market for these devices is primarily driven by the increasing global prevalence of ventral hernias, often exacerbated by factors such as an aging population and rising obesity rates. Furthermore, continuous advancements in surgical methodologies, including minimally invasive and robotic-assisted procedures, contribute significantly to market expansion by enhancing patient outcomes and reducing recovery times. According to the American College of Surgeons, approximately 1.5 million hernia repair procedures are performed annually in the United States.

However, a notable challenge impeding market growth involves concerns surrounding potential post-operative complications associated with mesh implantation, such as infection, chronic pain, and material degradation. Addressing these clinical concerns remains critical for sustained market acceptance and expansion within the surgical community.

Key Market Drivers

Rising incidence and growing patient population
The Global Ventral Hernia Mesh Devices Market is significantly influenced by the rising global incidence of ventral hernias. This increasing prevalence is often linked to factors such as an aging population and higher rates of obesity, which contribute to abdominal wall weakness. The substantial patient population requiring intervention drives consistent demand for effective repair solutions. According to a study published in PMC in June 2025, the global number of incident cases for inguinal, femoral, and abdominal hernias among older adults was 1.48 million in 2021, indicating a substantial patient population requiring repair. This demographic trend underscores a fundamental need for ventral hernia mesh devices to address the growing surgical caseload worldwide.

Adoption of minimally invasive techniques
Complementing this trend is the growing adoption of minimally invasive surgical techniques, including laparoscopic and robotic-assisted procedures. These advanced methods offer benefits such as reduced patient recovery times and decreased post-operative discomfort, thereby increasing their appeal to both surgeons and patients. Clinical registries documented a 27% year-on-year increase in laparoscopic and robotic hernia repair procedures in North America and Europe in 2025, underscoring the expanding preference for these techniques. The shift towards these less invasive approaches necessitates specialized mesh devices compatible with the instrumentation and procedural requirements of modern surgery. Further reflecting activity within the broader medical device sector relevant to surgical products, according to AlphaStreet, in April 2026, Baxter International Inc. reported first-quarter 2026 net sales of $2.70 billion, marking a 3% increase year-over-year.

Download Free Sample Report

Key Market Challenges

A notable challenge impeding market growth for ventral hernia mesh devices involves concerns surrounding potential post-operative complications associated with mesh implantation. These complications, which include infection, chronic pain, and material degradation, directly influence both patient and surgical community perceptions of mesh-based repairs. The heightened awareness of these risks can lead to patient apprehension and reluctance to undergo mesh-reinforced procedures, potentially driving preferences toward alternative surgical techniques or delaying necessary interventions. This hesitancy constrains the broader adoption of mesh devices, even given their demonstrated effectiveness in reducing hernia recurrence rates.

Such clinical concerns cultivate a cautious environment among surgeons, affecting their choice of mesh materials and placement techniques. The necessity for careful patient selection and extensive pre-operative counseling adds complexity to the surgical process. For instance, according to a 2025 JAMA Surgery study, the long-term risk of mesh removal due to infection was 2.2% at 10 years. These complication rates, irrespective of their overall incidence, contribute to increased healthcare resource utilization through potential reoperations and prolonged post-operative management, thereby directly limiting the market's potential for expansion.

Key Market Trends

A significant trend shaping the Global Ventral Hernia Mesh Devices Market is the continuous innovation in biocompatible and advanced mesh materials. This focus stems from the critical need to mitigate post-operative complications, such as infection and chronic pain, associated with traditional mesh materials. Manufacturers are increasingly developing absorbable and bio-integrated meshes that promote natural tissue remodeling and reduce long-term foreign body reactions. For example, according to BD, a leading global medical technology company, in April 2025, recent survey data indicated that 60% of patients prefer a non-permanent mesh option for hernia repair. This strong patient preference drives the demand for novel materials offering improved patient experiences and better long-term outcomes, thereby accelerating research and development efforts in this segment.

Another pivotal trend is the accelerated shift towards outpatient surgical settings for ventral hernia repair procedures. This transition is largely driven by desires for reduced healthcare costs, increased patient convenience, and advancements in minimally invasive surgical techniques that facilitate quicker recovery times. Outpatient facilities, such as ambulatory surgical centers, are becoming more prevalent, necessitating mesh devices that are compatible with streamlined procedures and optimized for rapid patient discharge. For instance, in a Medtronic clinical study evaluating the Hugo robotic-assisted surgery system, published in September 2025, the mean length of hospital stay was reported as 6.7 hours for ventral hernia patients. This move towards shorter hospital stays emphasizes the need for devices and techniques that support efficient, safe, and effective repairs outside traditional inpatient environments.

Segmental Insights

Robotic surgery stands out as the fastest-growing segment within the global ventral hernia mesh devices market. This rapid expansion is primarily driven by the enhanced precision, visualization, and control robotic platforms offer surgeons during complex procedures. These advantages facilitate technically demanding repairs, such as extraperitoneal mesh placement and abdominal wall reconstruction, often challenging with traditional minimally invasive methods. Furthermore, robotic-assisted techniques contribute to favorable patient outcomes, including reduced postoperative pain and shorter recovery times, thereby increasing their adoption in hernia repair. The ability to achieve robust fascial closure also plays a significant role in minimizing recurrence.

Regional Insights

North America stands out as the leading region in the Global Ventral Hernia Mesh Devices Market, demonstrating substantial market share. This dominance is attributed to a combination of factors, including the region's highly developed healthcare infrastructure and high healthcare expenditure. The presence of a large aging population and increasing obesity rates significantly contribute to a higher incidence of ventral hernias and, consequently, a greater volume of hernia repair surgeries annually. Moreover, North America benefits from heightened awareness regarding early disease detection, treatment options, and the early adoption of advanced surgical technologies and innovative mesh products.

Recent Developments

• In October 2025, TI Medical introduced its next-generation hernia repair mesh, the HIPOM-AB Mesh. This product was developed with a focus on enhancing both patient comfort and surgical precision in hernia repair. The HIPOM-AB Mesh features a large-pore design, which provides increased flexibility without compromising its structural strength. Additionally, it incorporates clear central markings to assist with accurate placement, a soft, absorbable edge to minimize tissue irritation, and pre-attached sutures to streamline positioning during surgical procedures. The mesh is designed to be used without prior preparation and can pass through standard laparoscopic instruments, featuring evenly distributed drainage holes to prevent fluid accumulation.
• In September 2025, Medtronic plc announced positive results from its Enable Hernia Repair clinical study, which assessed the performance of the Hugo™ robotic-assisted surgery (RAS) system in both inguinal and ventral hernia repair procedures. This study marked the first Investigational Device Exemption (IDE) clinical study completed for robotic-assisted hernia surgery within the United States. The findings demonstrated that the system met its primary safety and effectiveness endpoints, supporting the broader adoption of the Hugo RAS system for hernia repair. This development enhances the options available to surgeons for minimally invasive approaches, contributing to improved patient care and surgical outcomes.
• In June 2025, the Association of University Technology Managers (AUTM) recognized a breakthrough hernia mesh technology, the T-Line Hernia Mesh, for its significant impact. This innovative surgical device, which aims to reduce complications and improve outcomes in hernia repair procedures, was developed by North Carolina State University and Duke University researchers and is now licensed to Deep Blue Medical Advances. The recognition by AUTM’s Better World Project highlights how this academic research and subsequent technology transfer are leading to real-world advancements that enhance lives. This product exemplifies progress in the ventral hernia mesh devices market.
• In April 2025, BD (Becton, Dickinson and Company) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and commercially launched the Phasix™ ST Umbilical Hernia Patch. This product represents the first and only fully absorbable hernia patch on the market specifically designed for umbilical hernias. The patch is composed of poly-4-hydroxybutyrate (P4HB), a biologically-derived material, and integrates a hydrogel barrier. Its design facilitates deployment using techniques similar to traditional permanent mesh patches, offering surgeons a versatile and absorbable solution for umbilical hernia repair. This launch expands treatment options and advances biomaterial science in tissue reconstruction.

Key Market Players

• Medtronic plc
• Johnson & Johnson
• Becton, Dickinson and Company
• W. L. Gore & Associates
• Integra LifeSciences
• B. Braun Melsungen AG
• Cook Medical
• Hernia Mesh S.R.L.
• Tissium SA
• Atrium Medical Corporation

By Mesh Type	By Indication	By Procedure	By End Use	By Region
Resorbable Mesh Partially Absorbable Mesh Non-Resorbable Mesh	Umbilical Hernia Epigastric Hernia Incisional Hernia Others	Open Surgery Laparoscopic Surgery Robotic Surgery Others	Inpatient Facilities Outpatient Facilities	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Ventral Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Ventral Hernia Mesh Devices Market, By Mesh Type:

• Resorbable Mesh
• Partially Absorbable Mesh
• Non-Resorbable Mesh

• Ventral Hernia Mesh Devices Market, By Indication:

• Umbilical Hernia
• Epigastric Hernia
• Incisional Hernia
• Others

• Ventral Hernia Mesh Devices Market, By Procedure:

• Open Surgery
• Laparoscopic Surgery
• Robotic Surgery
• Others

• Ventral Hernia Mesh Devices Market, By End Use:

• Inpatient Facilities
• Outpatient Facilities

• Ventral Hernia Mesh Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE